A whiff of oxytocin increased activity in the social centers of the brain in a small study of children with autism. The findings were presented today at the International Meeting for Autism Research (IMFAR), in Toronto, Ontario.
Autism Speaks invites you to attend our first National Conference for Families and Professionals, August 3 and 4 in Columbus, Ohio. Registrations closes Friday, July 20, 2012.
A compound that inhibits the brain chemical glutamate reduced repetitive behaviors and partially improved sociability in mouse models of autism. Though preliminary, the findings represent an important advance in autism research because they are the first to show consistent benefits from a pharmaceutical agent across two core symptoms.
Autism researchers study the link between parental age and autism risk because the relationship provides important clues to the factors that lead to autism. For example, increasing age may bring greater cumulative exposure to toxic chemicals. Older moms have increased risk of pregnancy complications, and as a woman’s eggs age, they are more likely to carry genetic changes that can affect fetal development.
The Gordon Research Conference, “Fragile X and Autism-Related Disorders: From Basic Neuroscience to Improved Clinical Care,” will be held June 10 through 15, at Stonehill College, in Easton, Mass.